Skip to Content

Markets
Technicals
Companies
Earnings
Close-Up
Themes

News

Market and company headlines

CLPTAll

Loading

A personal project for following the US markets. Free, ad-free and open source.

Weekly Recap

Every Sunday morning: the week's earnings behind you and the calendar ahead, in one email.

Get It by Email

Market

Markets
Companies
Stock Screener
Macro
Earnings
Technical Analysis
Calendar
Compare
Thematic Lists
Famous Investors

Reading

Guide
Close-Up
Community
News
Brief Archive
Glossary
Tax Calculator
RSS

Account

Watchlist
My Posts
Bell Report
Portfolio
Settings
Privacy

© 2026 Opening BellPrivacy About What's New ContactNot Investment AdviceAhmet Akyapı

Markets Earnings Close-Up Menu

Nasdaq 100 · QQQ722.18+ 1.40%S&P 500 · SPY769.66+ 0.56%Dow Jones · DIA523.28+ 0.06%Russell 2000 · IWM280.18+ 1.15%

ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
SOLANA BEACH, CA / ACCESS Newswire / October 14, 2026 / (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2026 third quarter on Wednesday, October 28, 2026, after the market close.Investors and analysts are invited to listen to the live broadcast review of the Company's 2026 third quarter on Wednesday, October 28 at 4:30 p.
Yahoo16:0513 Days AgoCLPT+5.9%

06:00Oct 81 Story

AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +60.00% and -0.03%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo06:15

11:00Oct 71 Story

Cedar Grove Capital Q3 2026 Portfolio Update
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. Read more here.
SeekingAlpha11:48CLPT+5.9%

07:00Oct 11 Story

ClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To Hold
ClearPoint Neuro faces heightened uncertainty after uniQure's AMT-130 48-month data disappointed. Read more on CLPT stock here.
SeekingAlpha07:08CLPT+5.9%

08:00-10:00Sep 292 Stories

ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
ClearPoint Neuro (NASDAQ:CLPT) shares fell 24% on Tuesday following updated clinical trial results from partner uniQure N. V.
Yahoo09:30CLPT+5.9%
These stocks that are showing activity before the opening bell on Tuesday.
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
ChartMill08:30

04:00Sep 291 Story

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-market session. The company's market cap stands at $1.3 million. Summit Therapeutics (NASDAQ:SMMT) stock rose 16.34%
Benzinga04:05

06:00Sep 141 Story

Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Yahoo06:12